糖酸:新的潜在蛋白质标
P V Ershov1, E O Yablokov1, L A Kaluzhskiy1
1Institute of Biomedical Chemistry, Moscow, Russia.
Biomeditsinskaia khimiia
|September 4, 2025
概括
糖酸 (GA) 与88种肝脏蛋白相互作用,揭示了其分子机制. 这项研究确定了参与细胞代谢和疾病途径的关键蛋白质标,进步了我们对 GA 的理解.
科学领域:
- 药理学和生物化学
- 分子生物学
- 蛋白质组学
背景情况:
- 糖酸 (GA) 是一种天然的糖化物,具有生物活性,但其分子机制尚不完全理解.
- 确定GA的蛋白标对于阐明其药理动力学和潜在的治疗应用至关重要.
研究的目的:
- 在大鼠肝脏模型中实验性地确定与GA相互作用的组织特异性蛋白标.
- 研究GA结合蛋白的分子相互作用和细胞功能.
主要方法:
- 使用EAH-Sepharose 4B固定的GA来隔离与大鼠肝溶解物相互作用的蛋白质.
- 用于识别潜在的蛋白质标的质谱学.
- 凝染色学和半定量分析以评估GA对特定蛋白质的影响 (Aldh6a1,Decr1,Sod1).
- 分子对接模拟 (FlareTM) 模拟蛋白质-GA复合体并评估选择蛋白质 (Acox2,Acr1c9,Maoa,Mat1a,Nalcn) 的结合亲和力 (ΔG,Rank分数).
主要成果:
- 在大鼠肝组织中确定了88个与GA相互作用的潜在蛋白标.
- 证明GA对Aldh6a1,Decr1和Sod1蛋白质有影响.
- 分子对接确定了5种具有有利结合参数的蛋白质 (Acox2,Acr1c9,Maoa,Mat1a,Nalcn).
- 其中超过一半 (57%) 的蛋白质参与细胞代谢和生物转化过程.
结论:
- 这项研究提供了肝脏中潜在的GA蛋白点的综合清单,有助于了解其分子作用.
- 已确定的目标,特别是那些涉及新陈代谢的目标,为GA的各种生物活动和疾病关联提供了洞察力.
- 对这些蛋白-GA相互作用的进一步研究可以为涉及糖酸的新疗法铺平道路.
相关概念视频
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Protein Glycosylation
7.2K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
7.2K
G Protein-coupled Receptors
13.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.3K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Protein-protein Interfaces
13.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.2K


